GlassScriptPhysician profile
Erika Warton
NPI 1538821061
$4,417.76
in general payments reported to CMS, 2019-2025
34 companies · $1,698 in 2025
The $1,698 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $354 · 2024: $2,366 · 2025: $1,698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,397 · Education: $20.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,397.29 |
| Education | $20.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $951.49 | 2024-2025 | Tremfya, Stelara |
| Abbvie INC. | $750.55 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $250.51 | 2024 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $209.02 | 2024-2025 | Entyvio, Eohilia |
| Gilead Sciences, INC. | $176.58 | 2023-2025 | Livdelzi, Descovy |
| Edwards Lifesciences Corporation | $149.45 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Genzyme Corporation | $144.84 | 2024-2025 | |
| Inspire Medical Systems, INC. | $126.65 | 2024 | Inspire |
| Pfizer INC. | $125.85 | 2024-2025 | |
| Sage Therapeutics, LLC | $110.87 | 2024 | |
| Qol Medical, LLC | $107.40 | 2024-2025 | Sucraid, Sucraid |
| Novo Nordisk INC | $102.39 | 2025 | Wegovy |
| Exact Sciences Corporation | $98.66 | 2025 | Cologuard Collection Kit |
| Neurelis, INC. | $93.14 | 2024 | Valtoco |
| Sanofi-Aventis U.S. LLC | $90.22 | 2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $85.27 | 2023 | Ongentys |
| Evoke Pharma, INC. | $79.56 | 2024-2025 | |
| Celltrion USA INC. | $69.29 | 2024-2025 | Vegzelma, Zymfentra |
| Janssen Pharmaceuticals, INC | $61.98 | 2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.46 | 2024-2025 | Xifaxan, Trulance |
| Intercept Pharmaceuticals, INC. | $60.37 | 2024 | |
| Ardelyx, INC. | $60.03 | 2024-2025 | Ibsrela |
| Ironwood Pharmaceuticals, INC | $58.69 | 2024-2025 | |
| Ipsen Biopharmaceuticals, INC | $50.55 | 2024-2025 | Iqirvo |
| Organon LLC | $49.43 | 2024 | |
| Lilly USA, LLC | $48.30 | 2024-2025 | Omvoh |
| Madrigal Pharmaceuticals | $45.43 | 2024 | Resmetirom |
| Merck Sharp & Dohme LLC | $44.72 | 2024 | Dificid |
| Aimmune Therapeutics, INC. | $39.37 | 2024 | |
| Alnylam Pharmaceuticals INC. | $35.86 | 2023 | Givlaari |
| Regeneron Healthcare Solutions, INC. | $22.33 | 2024 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.11 | 2024 | Cyltezo |
| Fresenius Kabi USA, LLC | $19.73 | 2024 | Idacio |
| Daiichi Sankyo INC. | $17.66 | 2024 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Warton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.